tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Indaptus Therapeutics secures new funding and leadership shift
PremiumCompany AnnouncementsIndaptus Therapeutics secures new funding and leadership shift
2M ago
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
Premium
The Fly
Indaptus Therapeutics reports Q3 EPS ($2.98) vs ($9.04) last year
3M ago
Indaptus Therapeutics Advances Cancer Treatment with DECOY20 Clinical Study
Premium
Company Announcements
Indaptus Therapeutics Advances Cancer Treatment with DECOY20 Clinical Study
4M ago
Indaptus Therapeutics files to sell 2.16M shares of common stock for holders
PremiumThe FlyIndaptus Therapeutics files to sell 2.16M shares of common stock for holders
6M ago
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
Premium
The Fly
Indaptus Therapeutics reports Q2 EPS ($9.09) vs ($13.16) last year
6M ago
Indaptus Therapeutics Secures Approval for Private Placement
Premium
Company Announcements
Indaptus Therapeutics Secures Approval for Private Placement
7M ago
Indaptus Therapeutics Inc trading halted, volatility trading pause
PremiumThe FlyIndaptus Therapeutics Inc trading halted, volatility trading pause
8M ago
Indaptus Therapeutics Inc trading halted, news pending
Premium
The Fly
Indaptus Therapeutics Inc trading halted, news pending
8M ago
Indaptus Therapeutics Announces Reverse Stock Split
Premium
Company Announcements
Indaptus Therapeutics Announces Reverse Stock Split
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100